| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | See Remarks
1 company
Bergstrom Donald A is a President, R&D at Relay Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 21,581 | $7.72 | $166,676.60 | -2.5% | +70.3% | - | |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 30,897 | $7.29 | $225,239.13 | -5.6% | +0.9% | - | |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 30,770 | $3.69 | $113,477.74 | -2.6% | +103.9% | - | |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 31,562 | $3.02 | $95,381.30 | -2.6% | +8.7% | +289.2% | |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 986 | $2.84 | $2,800.24 | -0.2% | +9.0% | +221.1% | |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 80,450 | $4.50 | $362,298.11 | -4.3% | -26.7% | +68.7% | |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 657 | $4.38 | $2,877.66 | -0.1% | -31.4% | +96.3% | |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,688 | $6.06 | $16,289.28 | -0.5% | -21.7% | +24.7% | |
| Sep 27, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 648 | $7.51 | $4,866.48 | -0.1% | -40.3% | -30.7% | |
| Jul 29, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,698 | $8.85 | $23,877.30 | -0.5% | -26.6% | -55.9% |